X

Trial Profile

Phase I-II Study of Association of Deferasirox, Vitamin D and Azacytidine as Treatment of High Risk MDS (IPSS Int-2 and High)

Status: Active, no longer recruiting

Phase of Trial: Phase I/II

Latest Information Update: 07 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Deferasirox (Primary) ; Azacitidine; Colecalciferol
Indications Chronic myelomonocytic leukaemia; Myelodysplastic syndromes
Focus Adverse reactions; Therapeutic Use
Acronyms GFM-EXVD-AZA

Most Recent Events

09 Jan 2018 Status changed from recruiting to active, no longer recruiting.
11 Jul 2017 Planned End Date changed from 1 Feb 2018 to 1 Feb 2019.
11 Jul 2017 Planned primary completion date changed from 1 Feb 2017 to 1 Feb 2019.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com